Skip to main content
Erschienen in: BMC Cancer 1/2023

Open Access 01.12.2023 | Research

Cervical cancer survival prediction by machine learning algorithms: a systematic review

verfasst von: Milad Rahimi, Atieh Akbari, Farkhondeh Asadi, Hassan Emami

Erschienen in: BMC Cancer | Ausgabe 1/2023

Abstract

Background

Cervical cancer is a common malignant tumor of the female reproductive system and is considered a leading cause of mortality in women worldwide. The analysis of time to event, which is crucial for any clinical research, can be well done with the method of survival prediction. This study aims to systematically investigate the use of machine learning to predict survival in patients with cervical cancer.

Method

An electronic search of the PubMed, Scopus, and Web of Science databases was performed on October 1, 2022. All articles extracted from the databases were collected in an Excel file and duplicate articles were removed. The articles were screened twice based on the title and the abstract and checked again with the inclusion and exclusion criteria. The main inclusion criterion was machine learning algorithms for predicting cervical cancer survival. The information extracted from the articles included authors, publication year, dataset details, survival type, evaluation criteria, machine learning models, and the algorithm execution method.

Results

A total of 13 articles were included in this study, most of which were published from 2018 onwards. The most common machine learning models were random forest (6 articles, 46%), logistic regression (4 articles, 30%), support vector machines (3 articles, 23%), ensemble and hybrid learning (3 articles, 23%), and Deep Learning (3 articles, 23%). The number of sample datasets in the study varied between 85 and 14946 patients, and the models were internally validated except for two articles. The area under the curve (AUC) range for overall survival (0.40 to 0.99), disease-free survival (0.56 to 0.88), and progression-free survival (0.67 to 0.81), respectively from (lowest to highest) received. Finally, 15 variables with an effective role in predicting cervical cancer survival were identified.

Conclusion

Combining heterogeneous multidimensional data with machine learning techniques can play a very influential role in predicting cervical cancer survival. Despite the benefits of machine learning, the problem of interpretability, explainability, and imbalanced datasets is still one of the biggest challenges. Providing machine learning algorithms for survival prediction as a standard requires further studies.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
OS
Overall Survival
PFS
Progression-free Survival
DFS
Disease-free Survival
C-index
Concordance Index
PNN
Probabilistic Neural Network
ANN
Artificial Neural Network
MLP
Multilayer Perceptron Network
GEP
Gene Expression Programming
SVM
Support Vector Machines
RBFNN
Radial Basis Function Neural Network
RF
Random Forest
LR
Logistic Regression
NB
Naïve Bayes
ML
Machine Learning
DL
Deep Learning
KNN
K-nearest Neighbors
DVH
Dose-volume Histogram
WSI
Whole Slide Image, EL: Ensemble Learning
HL
Hybrid Learning
TCGA
The Cancer Genome Atlas
GEO
Gene Expression Omnibus
SEER
Surveillance, Epidemiology, and End Results
H&E L
Hybrid and Ensemble learning
MAE
Mean Absolute Error
PPV
Positive Predictive Value
NPV
Negative Predictive Value
AUC
Area Under the Curve
HIS
Hospital Information Systems
EHR
Electronic Health Record
PET
Positron Emission Tomography
CT
Computed Tomography
BMI
Body Mass Index
HPV
Human Papillomavirus

Introduction

Cervical cancer is the fourth most common cancer in the female reproductive system and the seventh most common cancer worldwide. There is a higher likelihood of cancer tumors growing in areas where endocervix cells become exocervix cells or near the Squamocolumnar Junction (SCJ). Cervical cancer is one of the main factors related to the death of females worldwide [1]. According to the World Health Organization (WHO) cervical cancer report in 2020, there were about 604,127 diagnosed cases and 341,831 deaths worldwide, of which 1,056 diagnosed cases and 644 deaths occurred in Iran [2]. Sexually transmitted diseases, multiple partners, smoking, weak nutrition, and the immune system play a role in the growth and development of cervical cancer [3]. An important risk factor for cervical cancer is the persistence of human papillomavirus (HPV), especially genotypes 16 and 18 [4]. Although about 90% of human papillomavirus infections heal by themselves within two years, some may also lead to the growth of cancerous masses in the cervix [5, 6]. Diagnosing a cancerous mass in the early stages increases the patient’s chance of survival and treatment. In late diagnosis, the possibility of complete recovery of the patient decreases [7]. Cervical cancer is entirely preventable and treatable if pre-cancer symptoms are identified at an early stage. The pap smear is frequently used for cervix medical diagnosis to track cervical cancer. A few cervical cell samples are taken, a cell smear is made, the cells are examined under a microscope for abnormalities, and the result is a diagnosis of the cervical condition [8]. Physicians consider the patient's chance of survival to guide their treatment plan.
Survival prediction is a set of statistical methods for data analysis, where the outcome variable is the time to an event. In other words, survival prediction is calculated by considering the time between exposure to the event and the occurrence of the event [9]. According to the American Society of Clinical Oncology (ASCO), the average 5-year overall survival rate for cervical cancer is 66%, i.e., about 66% of people diagnosed with cervical cancer today will survive for at least the next five years. The best treatment method for each patient can be adopted by evaluating the patient’s clinical and treatment data to accurately predict the patient’s survival. Researchers have often used classical statistical methods such as non-parametric, parametric, and semi-parametric (COX) tests to predict survival [10]. In recent years, artificial intelligence algorithms, with their impressive capabilities, have been in fierce competition with statistical tests and have grown significantly in survival prediction.
Big data are being generated and stored with the rapid growth of digital technologies in healthcare and the evolution of electronic health records (EHR) [11]. Classical statistical methods often focus on the relationship between dependent variables to achieve the final result, but machine learning algorithms can learn hidden patterns in data. Machine learning algorithms do not require implicit assumptions and can manage non-linear relationships between variables [12]. Machine learning makes computers intelligent without directly teaching them how to make decisions and solve problems [13]. Today, machine learning algorithms have been studied and developed in the diagnosis, prognosis, and prediction of the occurrence of many diseases [14], which performed very well in dealing with Big data [15].
This study aimed to evaluate published studies on machine learning algorithms in predicting the survival of patients with cervical cancer, considering overall, disease-free, and progression-free survival.

Materials and methods

This systematic review examined original articles that used machine learning algorithms to predict the survival of patients with cervical cancer and discovered knowledge.

Study selection

The article selection method was based on the Preferred Protocol for Systematic Reviews and Meta-Analysis (PRISMA) and the retrieved articles were imported into Excel software. The first search returned 229 articles, then 45 review articles and 85 duplicate articles were removed. A total of 99 items remained for screening based on the eligibility criteria. During the screening process, 70 articles were excluded by title and abstract verification, and 16 articles were excluded based on method, results, or study design nature. The screening process was performed twice to reduce errors. Any discrepancies were resolved through discussions with the second and third authors. Finally, 13 articles were thoroughly examined and included in the study (Fig. 1).

Search strategy

Articles published until October 1, 2022, were collected from three electronic databases, PubMed, Scopus, and Web of Science, and the search query consisted of three basic parts. The first part was about cervical cancer, which included two keywords of "cervical cancer" and "Uterine Cervical Neoplasms". The second part was about predicting survival with one keyword named "Survival", and the third part was about artificial intelligence with three keywords, including "Machine learning", "Deep learning", and "Artificial Intelligence." Details are available in Table 1.
Table 1
Keywords and search strategy in three databases: PubMed, Scopus, and Web of Science
#1: (Uterine Cervical Neoplasms OR Cervical Cancer)
#2: (Survival)
#3: (Machine Learning OR Deep Learning OR Artificial Intelligence)
Search strategy: #1 AND #2 AND #3
PUBMED:
(Uterine Cervical Neoplasms[Title/Abstract] OR Cervical Cancer[Title/Abstract]) AND (Survival[Title/Abstract]) AND (Machine Learning[Title/Abstract] OR Deep Learning[Title/Abstract] OR Artificial Intelligence[Title/Abstract])
SCOPUS:
(TITLE-ABS-KEY(Uterine Cervical Neoplasms) OR TITLE-ABS-KEY(Cervical Cancer)) AND (TITLE-ABS-KEY(survival)) AND (TITLE-ABS-KEY(Machine Learning) OR TITLE-ABS-KEY(Deep Learning) OR TITLE-ABS-KEY(Artificial Intelligence))
WEB OF SCIENCE:
(TS = (Uterine Cervical Neoplasms) OR TS = (Cervical Cancer)) AND (TS = (Survival)) AND (TS = (Machine Learning) OR TS = (Deep Learning) OR TS = (Artificial Intelligence))

Inclusion and exclusion criteria

This study included original articles and full English text, which used machine learning algorithms as predictive models for cervical cancer survival.
Books, review articles, meta-analyses, case reports, posters and case studies were filtered. In addition, articles that did not sufficiently focus on the implementation of machine learning algorithms, cervical cancer, and model outputs were excluded in the screening section. All entry and exit criteria are listed in Table 2.
Table 2
Inclusion and exclusion criteria for articles in the study
Inclusion criteria
Exclusion criteria
Full text access
Book
Full text English
Review and Meta-analysis
Original articles
Letters to the editor
 
Short article and Poster
 
Case report

Results

From the initial search results, 229 articles were found, of which only 13 articles met the study criteria and were included in the study for further investigation. All included articles were retrospective and used machine learning algorithms as modeling to predict cervical cancer survival.

Characteristics of studies

Most of the imported articles were published from 2018 onwards, and the last was from 2022 (Table 3). Table 4 provides additional information and a general view of the included studies. A total of eight articles were performed in Asia [1623], four in Europe [2427], and one in the United States [28]. Generally, eight articles on overall survival (OS) [17, 1921, 23, 2628], six articles on disease-free survival (DFS) [16, 18, 2124], and three articles on survival progression-free (PFS) [19, 25, 28] were used to predict the survival of patients with cervical cancer. Moreover, two articles were excluded from the study due to the use of machine learning algorithms only as a tool for feature selection [29, 30].
Table 3
Extracted characteristics of the included articles
Author, Year
Country
Data source
# Samples
Hyperparameter tuning
Pre-processing
Feature selection
Survival
Data types
ML algorithms
Validation
Evaluation
Liang, 2022 [17]
China
SEER (2010 to 2015)
14946
No
Yes
Yes
OS
Clinical
LR
Internal
C-index
Ding, 2021 [20]
China
The cancer Genome Atlas
542
No
Yes
Yes
OS
Molecular Clinical
SVM
Internal
AUC
Obrzut, 2017 [27]
Poland
Rzeszow State Hospital (1998 to 2001)
117
No
Yes
No
OS
Clinical
PNN
MLP
GEP
SVM
RBFNN
K-Means
Internal
Accuracy Sensitivity
Specificity
AUC
Carlini, 2022 [26]
Italy
IRCCS University Hospital
85
Yes
Yes
Yes
OS
PET/CT
RF
Internal
C-index
Ferreira, 2021 [24]
Belgium
Liege University Hospital (2010 to 2016)
158
Yes
Yes
Yes
DFS
PET/CT Clinical
RF
SVM
NB
LR
External
AUC
F1-score
Precision
Sensitivity
Takada, 2020 [16]
Japan
Chiba Hospital (2012 to 2016)
107
No
Yes
Yes
DFS
Clinical MRI
RF
Internal
AUC
Senthilkumar, 2021 [18]
India
GEO
300
Yes
Yes
Yes
DFS
Molecular
EL
CoxLasso
External
Precision
F1-score
Accuracy
Sensitivity
Shen, 2019 [22]
Taiwan
(2009 to 2015)
142
No
Yes
Yes
DFS
Clinical PET/CT
DL
Internal
Sensitivity
Specificity
Accuracy
PPV
NPV
Arezzo, 2021 [25]
Italy
University of Bari, (2010 to 2018)
92
Yes
No
Yes
PFS
Clinical MRI
LR
RF
KNN
Internal
Accuracy
TPR
Precision
AUC
Guo, 2021 [21]
China
multi-center (2006 to 2017)
5112
Yes
No
Yes
OS; DFS
Clinical
GBDT
RF
Internal
C-index
MAE
Chen, 2022 [23]
China
Nanfang Hospital (2009–2016)
251
No
Yes
Yes
OS; DFS
Clinical WSI
DL
Internal
C-index
AUC
Matsuo, 2019 [28]
USA
California Medical Center (2000 to 2014)
768
Yes
No
Yes
OS; PFS
Clinical
CoxBoost
CoxLasso
RF
DL
Internal
C-index
MAE
Kim, 2021 [19]
Korea
Multi-center (2000 to 2018)
1056
No
Yes
Yes
OS; PFS
Clinical
LR
HL
Internal
AUC
PNN Probabilistic neural network, ANN Artificial neural network, MLP Multilayer perceptron network, GEP Gene expression programming classifier, SVM Support vector machines, RBFNN Radial basis function neural network, RF Random Forest, LR Logistic regression, NB Naïve bayes, DL Deep learning, KNN K-nearest neighbors, DVH Dose-volume Histogram, OS, Overall survival, DFS Disease-free survival, PFS progression-free survival, WSI Whole slide image, EL Ensemble learning, HL Hybrid learning
Table 4
Classification of the features of the included articles
Characteristics
Categories
Number (n)
OS
DFS
PFS
Location
Asia
5 [17, 1921, 23]
5 [16, 18, 2123]
1 [19]
Europe
2 [26, 27]
1 [24]
1 [25]
USA
1 [28]
-
1 [28]
Dataset sources
Hospitals
6 [19, 21, 23, 2628]
5 [16, 2124]
3 [19, 25, 28]
SEER
1 [17]
-
-
TCGA
1 [20]
-
-
GEO
-
1 [18]
-
Dataset privacy
Public
2 [17, 20]
1 [18]
-
Private
6 [19, 21, 23, 2628]
5 [16, 2124]
3 [19, 25, 28]
Data source
Single
6 [17, 20, 23, 2628]
5 [16, 18, 2224]
2 [25, 28]
Multiple
2 [19, 21]
1 [21]
1 [19]
Preprocessing
Yes
6 [17, 19, 20, 23, 26, 27]
5 [16, 18, 2224]
1 [19]
No
2 [21, 28]
1 [21]
2 [25, 28]
Feature selection
Yes
7 [17, 1921, 23, 26, 28]
6 [16, 18, 2124]
3 [19, 25, 28]
No
1 [27]
-
-
# Models
One
4 [17, 20, 23, 26]
3 [16, 22, 23]
-
Two or more
4 [19, 21, 27, 28]
3 [18, 21, 24]
3 [19, 25, 28]
Models type
RF
3 [21, 26, 28]
3 [16, 21, 24]
2 [25, 28]
LR
1 [19]
2 [17, 24]
2 [19, 25]
SVM
2 [20, 27]
1 [24]
-
DL
2 [23, 28]
2 [22, 23]
-
H&E L
2 [19, 21]
2 [18, 21]
1 [19]
Validation
Internal
8 [17, 1921, 23, 2628]
4 [16, 2123]
3 [19, 25, 28]
External
-
2 [18, 24]
-
Evaluation metrics
AUC
4 [19, 20, 23, 27]
4 [16, 19, 23, 24]
1 [25]
C-index
5 [17, 19, 21, 23, 26]
2 [21, 23]
1 [19]
Sensitivity
1 [27]
3 [18, 22, 24]
-
Precision
-
2 [18, 24]
1 [25]
Specificity
1 [27]
1 [22]
-
Accuracy
1 [27]
2 [18, 22]
1 [25]
F1-score
-
2 [18, 24]
-
MAE
2 [21, 28]
1 [21]
1 [28]
NPV / PPV
-
1 [22]
-
Data types
Clinical
5 [17, 19, 21, 27, 28]
1 [21]
2 [19, 28]
Image
1 [26]
-
-
Molecular
-
1 [18]
-
Clinical + Image
1 [23]
4 [16, 2224]
1 [25]
Clinical + Molecular
1 [20]
-
-
TCGA The cancer Genome Atlas, GEO Gene Expression Omnibus, SEER Surveillance, Epidemiology, and End Results, RF Random Forest, SVM Support Vector Machine, LR Logistic regression, DL Deep Learning, H&E L Hybrid and Ensemble learning, MAE Mean absolute error

Database information

Ten articles used hospital and clinic datasets [16, 19, 2128], and three articles each used the cancer genome atlas [20], SEER [17], and Geo [18]. The datasets used in the three articles were more detailed and open to public access [17, 18, 20], but private datasets were used in the other ten articles. The maximum and minimum sizes of the datasets used for modeling were 14,946 and 85 records, respectively, and the datasets had more than 1000 records only in three articles [17, 19, 21].

Data preprocessing

A total of 11 articles used data preprocessing techniques [1626], and three mentioned missing data [18, 19, 25]. Selected approaches to handle missing data included record deletion, multiple imputations, and the nearest neighbor algorithm. The feature selection approach was used in all the articles except article [27], but only eight articles specified the details [16, 18, 20, 21, 2326]. Logistic regression [24], Naive Bayes [24], Random Forest [24], Genetic algorithm [26], lasso [17, 18, 25, 27], k-means [19, 20], Support vector machine [18, 19, 26, 28], AdaBoost [18], Elastic-net [23], recurrent feature elimination (RFE) [16, 25], and deep learning [22, 23, 28] were among the algorithms used for feature selection and extraction. Two articles mentioned the management of outlier data [16, 20], but only one provided more details [16].
Imbalanced data in the dataset causes a lack of generalizability in the model and is considered a serious challenge [31]. The challenge of unbalanced data in the dataset was discussed in two articles [25, 26], and the RF cost-sensitive method was used to overcome this challenge in one article [25].

Data modeling

The model was calibrated in three articles [16, 18, 25], but the work details were not provided. Hyperparameter tuning was used in model training in six articles, but only four shared the work details [18, 24, 25, 28].
Six articles used only one machine learning algorithm to build the model [16, 17, 20, 22, 23, 26]. Further, two or more machine learning algorithms were used in seven articles, and their output was compared with each other [18, 19, 21, 24, 25, 27, 28]. The most frequent machine learning algorithms were random forest, logistic regression, support vector machine, deep learning, and ensemble and hybrid learning.

Model validation

The selected articles were based on internal validation in 11 articles and external validation in two articles [18, 24]. Most of the studies related to internal validation used the cross-validation method.
The most common criteria for evaluating the algorithm performance in the articles were the model AUC from 0.40 to 0.99 in seven articles, regardless of the type of survival. C-index was 0.39 to 0.94 in 5 articles, and the accuracy was 0.61 to 0.92 in 4 articles. In three articles, sensitivity and F1-score were 0.20 to 0.97 and 0.22 to 0.92, respectively. More details were shown in Table 5.
Table 5
Classification of the used evaluation criteria into types of survival from the lowest to the highest
Evaluation method
OS
DFS
PFS
Min
Max
Min
Max
Min
Max
AUC
0.40
0.99
0.56
0.88
0.67
0.81
C-index
0.39
0.94
0.41
0.89
0.69
0.79
Sensitivity
0.75
0.97
0.20
0.93
-
-
Specificity
0.0
0.60
0.93
0.93
-
-
Precision
-
-
0.33
91.14
76.5
80.1
Accuracy
0.61
0.89
0.84
0.92
0.73
0.84
F1-score
-
-
0.22
0.92
-
-
Mean Absolute Error
21.18
39.2
11.24
12.43
28.8
29.3
Table 5 description: All of the articles that employed the selected criteria were split according to the kind of survival, and the minimum and maximum rates for each criterion were then shown
Regarding articles with more than one model, ensemble and hybrid models in 3 articles [18, 19, 21], random forest in 3 articles [2426], logistic regression [17], and deep learning [28] in 1 article had the best performance.

Important variables

Clinical tabular data were used as model inputs in 11 articles [16, 17, 1925, 27, 28], which were the only model inputs in five articles [17, 19, 21, 27, 28]. Image-based data was used [16, 2226] in six articles, one of which applied the machine learning model trained only with images [26]. In two articles, molecular data were used to predict survival [18, 20]. According to the output of all survival prediction models, cancer stage variables, histology, treatment method, and tumor-related information have significantly affected cervical cancer survival prediction. The important variables extracted from the included articles are shown in Table 6.
Table 6
Influential variables in predicting types of survival extracted from articles
Selected Features
OS (n)
DFS (n)
PFS (n)
FIGO Stage
5 [17, 20, 21, 23, 25]
4 [16, 2123]
2 [19, 25]
Heart Rate
1 [25]
-
1 [25]
Laboratory test
1 [25]
-
1 [25]
Treatment type
3 [17, 21, 25]
1 [21]
2 [19, 25]
Race/ethnicity
2 [20, 25]
-
1 [25]
Hypertension
-
-
1 [25]
Histopathology
4 [1921, 23]
5 [16, 2124]
1 [25]
Age
3 [17, 20, 23]
3 [2224]
1 [25]
Height
1 [20]
-
-
Tumor Size
3 [19, 21, 23]
3 [16, 21, 23]
-
Lymph Node metastasis
3 [19, 21, 23]
3 [2224]
1 [19]
positive lymph node numbers
1 [23]
1 [23]
-
Lymph vascular space invasion
1 [23]
1 [23]
-
BMI
-
-
1 [25]
HPV
1 [20]
-
-
BMI Body Mass Index, HPV Human Papillomavirus
Table 6 description: From the entered articles, all variables that could reliably predict cervical cancer survival were retrieved, categorised, and then displayed according to the type of survival.

Discussion

A systematic review of 229 articles resulted in the inclusion of 13 articles. The selected articles contained qualitative and quantitative information about predicting and analyzing the survival of cervical cancer patients using machine learning algorithms. The number of articles using machine learning algorithms to predict cervical cancer survival was few. Studies related to all three types (overall survival, disease-free survival, and progression-free survival) were inevitably included in the study due to the variation in survival and the small number of studies specific to each type of survival.
The three included studies that used open-access databases were more transparent and competitive in preprocessing and model building. Multiple researchers can analyze open-access databases to discover the most valuable features and the best machine-learning model for that particular dataset. Another essential thing even mentioned in the article [32] was the correlation of the model output with the data of a specific geographical environment and the change of medical prescriptions over time. Generalizability and the time interval between data collection and modeling can be evaluated in the applicability of the model output. Databases with open access were more suitable and valuable for studying and predicting survival.
The included articles used datasets with different sizes and types for modeling. The largest dataset included in the study was related to the article [17], with 14,946 clinical tabular data and C-index (0.86). The smallest dataset included in the study is related to the article [26] with 85 image data records (PET/CT) and C-index (0.77). Image datasets had fewer records than other datasets among the imported articles. According to the reports of (Illia Horenko) [33], small datasets used in model training often cause overfitting of the model and reduce the model’s capacity for generalization. Image datasets sometimes make the model more accurate than tabular data, which can be caused by the power of image processing algorithms [34]. Feature extraction, feature selection, transfer learning, fine-tuning, augmentation, object segmentation, and object detection were the most critical advantages of image processing algorithms [3436]. In addition to the cases mentioned, convolutional neural networks obtained valuable results on 3D images [37]. Recently, medical image datasets have been used to predict the survival of patients. However, larger image datasets and more optimal convolutional neural network structures should reach a robust model.
Only two of the articles included in this study had external validation. Article [18] with molecular data and the other article [24] with the combination of clinical tabular data and images (PET/CT) obtained precision of 0.82 and 0.42 respectively. The model’s generalizability is more reliable in external validation due to the use of different data. Most included articles used the five-fold cross-validation method for internal validation. Cross-validation is a resampling method for evaluating a model with limited data [38]. The advent of open-access datasets and standard databases of medical data has made it more feasible to evaluate models using external validation methods.
Data wrangling and preprocessing play an essential role in modeling and model output. Medical datasets often include noise, redundant data, outliers, missing data, and irrelevant variables [39]. Hoeren mentioned that the actual value of data lies in its usability [40], and data quality is the most critical concern in model training. Data cleaning is one of the essential solutions in the data preprocessing stage for reducing errors, preventing model bias caused by dirty data, and obtaining the best results [41]. Therefore, data preprocessing such as cleaning, transformation, reduction, and integration, should be conducted properly, which includes 70–80% of the training and model workload [42]. All the included studies paid attention to this principle.
Among all the included articles, six used hyperparameter tuning and feature selection methods in their study [18, 21, 2426, 28]. Studies often used hyperparameter tuning and feature selection to avoid overfitting or to achieve high-accuracy models [24, 25]. According to articles [25, 32], selecting appropriate modeling variables directly affected the model’s output. Therefore, feature selection, extraction, reduction, and engineering are necessary to reach an ideal model. Hyperparameter tuning is one of the essential steps in the model-building pipeline, which can produce a model with high accuracy by finding the most optimal input parameters. Most of the entered studies used the Grid search method for this operation. Considering that feature selection in convolutional neural networks is done automatically, having background knowledge can enhance the model’s reliability. Approaches such as Bayesian Optimization and Evolutionary algorithms like Genetic Algorithms [26] and Artificial Fish Swarm [18] can be more suitable approaches for hyperparameter tuning and feature selection.
Recently, the use of Hybrid and Ensemble models has increased in the medical field, especially in predicting survival. Three of the included studies that used the abovementioned methods to predict survival have obtained acceptable accuracy and precision [18, 19, 21]. Random forest (RF) and Extreme Gradient Boosting (XGBoost) models are also among Ensemble learning (EL) algorithms [26]. Developing and optimizing machine learning models using hybrid and ensemble techniques continuously improve computational aspects, performance, generalizability, and accuracy [43]. Ensemble models, like deep learning algorithms, have spontaneous feature selection ability. In these two Ensemble and Hybrid learning methods, several models with weak learners are trained to solve a specific problem and combined to achieve better results [44].
Most studies have used a combination of clinical, imaging, and molecular data to predict survival to achieve greater accuracy in training machine learning models. Articles [2225] used a combination of clinical data types with more accuracy and reliability. Most articles that used composite data to predict cervical cancer survival occurred from 2021 onwards. Random forest and deep learning were the most used in mixed data modeling. All types of patient data, with the help of artificial intelligence, can play a significant role in Precision Medicine.
With recent advances in artificial intelligence, deep learning algorithms have undeniably gained power as well. Deep learning algorithms are able to recognize patterns from large, extensive and heterogenous data. They have also provided an admirable ability to process image, video, text, audio and signals [45]. According to comparative studies, it has been determined that artificial intelligence has a better performance than classical statistics [45]. With the daily advancement of technologies and the rapid expansion of artificial intelligence science, we will see the use of transformers [46], meta learning [47] and quantum machine learning [48] in medical data processing in the near future. Nevertheless, solutions to the questions of interpretability and explainability should be considered together with the immense potential of AI in health research [49].

Conclusions

Recording and storing patient information has become easy and is overgrowing due to the growth and improvement of hospital information systems (HIS) and electronic health record systems (EHRs). Classical statistical models such as Cox are used in many survival studies but are no longer compatible with many medical data. Today, machine learning algorithms have become a focal point in research and development because of their unique abilities in pattern recognition in data, feature selection and extraction, and great power in medical image processing.
Most of the survival articles of the last few years have used machine learning algorithms to predict the survival of cervical cancer patients. Combining heterogeneous multidimensional data with machine learning techniques could affect the prediction of cervical cancer survival. The low or lack of explainability in machine learning algorithms has prevented the official use of artificial intelligence models in health. Machine learning is more accurate than other statistical methods in predicting the survival of cervical cancer patients, but more studies are needed to become a standard.

Acknowledgements

Not applicable

Declarations

Not applicable.
Not applicable.

Competing interests

The authors declare no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Terasawa T, Hosono S, Sasaki S, Hoshi K, Hamashima Y, Katayama T, et al. Comparative accuracy of cervical cancer screening strategies in healthy asymptomatic women: a systematic review and network meta-analysis. Sci Rep. 2022;12(1):94.PubMedPubMedCentralCrossRef Terasawa T, Hosono S, Sasaki S, Hoshi K, Hamashima Y, Katayama T, et al. Comparative accuracy of cervical cancer screening strategies in healthy asymptomatic women: a systematic review and network meta-analysis. Sci Rep. 2022;12(1):94.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.PubMedCrossRef Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.PubMedCrossRef
3.
4.
Zurück zum Zitat Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.PubMedCrossRef Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.PubMedCrossRef
5.
Zurück zum Zitat Gates A, Pillay J, Reynolds D, Stirling R, Traversy G, Korownyk C, et al. Screening for the prevention and early detection of cervical cancer: protocol for systematic reviews to inform Canadian recommendations. Syst Rev. 2021;10(1):2.PubMedPubMedCentralCrossRef Gates A, Pillay J, Reynolds D, Stirling R, Traversy G, Korownyk C, et al. Screening for the prevention and early detection of cervical cancer: protocol for systematic reviews to inform Canadian recommendations. Syst Rev. 2021;10(1):2.PubMedPubMedCentralCrossRef
6.
8.
Zurück zum Zitat Wang C-W, Liou Y-A, Lin Y-J, Chang C-C, Chu P-H, Lee Y-C, et al. Artificial intelligence-assisted fast screening cervical high grade squamous intraepithelial lesion and squamous cell carcinoma diagnosis and treatment planning. Sci Rep. 2021;11(1):16244.PubMedPubMedCentralCrossRef Wang C-W, Liou Y-A, Lin Y-J, Chang C-C, Chu P-H, Lee Y-C, et al. Artificial intelligence-assisted fast screening cervical high grade squamous intraepithelial lesion and squamous cell carcinoma diagnosis and treatment planning. Sci Rep. 2021;11(1):16244.PubMedPubMedCentralCrossRef
9.
10.
Zurück zum Zitat Wang P, Li Y, Reddy CK. Machine learning for survival analysis: A survey. ACM Computing Surveys (CSUR). 2019;51(6):1–36.CrossRef Wang P, Li Y, Reddy CK. Machine learning for survival analysis: A survey. ACM Computing Surveys (CSUR). 2019;51(6):1–36.CrossRef
11.
Zurück zum Zitat Paydar S, Emami H, Asadi F, Moghaddasi H, Hosseini A. Functions and outcomes of personal health records for patients with chronic diseases: a systematic review. Perspect Health Inf Manag. 2021;18(Spring):1l.PubMedPubMedCentral Paydar S, Emami H, Asadi F, Moghaddasi H, Hosseini A. Functions and outcomes of personal health records for patients with chronic diseases: a systematic review. Perspect Health Inf Manag. 2021;18(Spring):1l.PubMedPubMedCentral
13.
Zurück zum Zitat Samuel AL. Some studies in machine learning using the game of checkers. IBM J Res Dev. 2000;44(1.2):206–26.CrossRef Samuel AL. Some studies in machine learning using the game of checkers. IBM J Res Dev. 2000;44(1.2):206–26.CrossRef
14.
Zurück zum Zitat Xu Y, Ju L, Tong J, Zhou C-M, Yang J-J. Machine learning algorithms for predicting the recurrence of stage IV colorectal cancer after tumor resection. Sci Rep. 2020;10(1):2519.PubMedPubMedCentralCrossRef Xu Y, Ju L, Tong J, Zhou C-M, Yang J-J. Machine learning algorithms for predicting the recurrence of stage IV colorectal cancer after tumor resection. Sci Rep. 2020;10(1):2519.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Sheidaei A, Foroushani AR, Gohari K, Zeraati H. A novel dynamic Bayesian network approach for data mining and survival data analysis. BMC Med Inform Decis Mak. 2022;22(1):251.PubMedPubMedCentralCrossRef Sheidaei A, Foroushani AR, Gohari K, Zeraati H. A novel dynamic Bayesian network approach for data mining and survival data analysis. BMC Med Inform Decis Mak. 2022;22(1):251.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Takada A, Yokota H, Watanabe Nemoto M, Horikoshi T, Matsushima J, Uno T. A multi-scanner study of MRI radiomics in uterine cervical cancer: prediction of in-field tumor control after definitive radiotherapy based on a machine learning method including peritumoral regions. Jpn J Radiol. 2020;38(3):265–73.PubMedCrossRef Takada A, Yokota H, Watanabe Nemoto M, Horikoshi T, Matsushima J, Uno T. A multi-scanner study of MRI radiomics in uterine cervical cancer: prediction of in-field tumor control after definitive radiotherapy based on a machine learning method including peritumoral regions. Jpn J Radiol. 2020;38(3):265–73.PubMedCrossRef
17.
Zurück zum Zitat Liang J, He T, Li H, Guo X, Zhang Z. Improve individual treatment by comparing treatment benefits: Cancer artificial intelligence survival analysis system for cervical carcinoma. J Transl Med. 2022;20(1):1–15.CrossRef Liang J, He T, Li H, Guo X, Zhang Z. Improve individual treatment by comparing treatment benefits: Cancer artificial intelligence survival analysis system for cervical carcinoma. J Transl Med. 2022;20(1):1–15.CrossRef
18.
Zurück zum Zitat Senthilkumar G, Ramakrishnan J, Frnda J, Ramachandran M, Gupta D, Tiwari P, et al. Incorporating artificial fish swarm in ensemble classification framework for recurrence prediction of cervical cancer. IEEE Access. 2021;9:83876–86.CrossRef Senthilkumar G, Ramakrishnan J, Frnda J, Ramachandran M, Gupta D, Tiwari P, et al. Incorporating artificial fish swarm in ensemble classification framework for recurrence prediction of cervical cancer. IEEE Access. 2021;9:83876–86.CrossRef
19.
Zurück zum Zitat Kim SI, Lee S, Choi CH, Lee M, Suh DH, Kim HS, et al. Machine learning models to predict survival outcomes according to the surgical approach of primary radical hysterectomy in patients with early cervical cancer. Cancers. 2021;13(15):3709.PubMedPubMedCentralCrossRef Kim SI, Lee S, Choi CH, Lee M, Suh DH, Kim HS, et al. Machine learning models to predict survival outcomes according to the surgical approach of primary radical hysterectomy in patients with early cervical cancer. Cancers. 2021;13(15):3709.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Ding D, Lang T, Zou D, Tan J, Chen J, Zhou L, et al. Machine learning-based prediction of survival prognosis in cervical cancer. BMC Bioinformatics. 2021;22(1):1–17.CrossRef Ding D, Lang T, Zou D, Tan J, Chen J, Zhou L, et al. Machine learning-based prediction of survival prognosis in cervical cancer. BMC Bioinformatics. 2021;22(1):1–17.CrossRef
21.
Zurück zum Zitat Guo C, Wang J, Wang Y, Qu X, Shi Z, Meng Y, et al. Novel artificial intelligence machine learning approaches to precisely predict survival and site-specific recurrence in cervical cancer: a multi-institutional study. Translat Oncol. 2021;14(5):101032.CrossRef Guo C, Wang J, Wang Y, Qu X, Shi Z, Meng Y, et al. Novel artificial intelligence machine learning approaches to precisely predict survival and site-specific recurrence in cervical cancer: a multi-institutional study. Translat Oncol. 2021;14(5):101032.CrossRef
22.
Zurück zum Zitat Shen W-C, Chen S-W, Wu K-C, Hsieh T-C, Liang J-A, Hung Y-C, et al. Prediction of local relapse and distant metastasis in patients with definitive chemoradiotherapy-treated cervical cancer by deep learning from [18F]-fluorodeoxyglucose positron emission tomography/computed tomography. Eur Radiol. 2019;29(12):6741–9.PubMedCrossRef Shen W-C, Chen S-W, Wu K-C, Hsieh T-C, Liang J-A, Hung Y-C, et al. Prediction of local relapse and distant metastasis in patients with definitive chemoradiotherapy-treated cervical cancer by deep learning from [18F]-fluorodeoxyglucose positron emission tomography/computed tomography. Eur Radiol. 2019;29(12):6741–9.PubMedCrossRef
23.
Zurück zum Zitat Chen C, Cao Y, Li W, Liu Z, Liu P, Tian X, et al. The pathological risk score: a new deep learning-based signature for predicting survival in cervical cancer. Cancer Med. 2023;12(2):1051–63.PubMedCrossRef Chen C, Cao Y, Li W, Liu Z, Liu P, Tian X, et al. The pathological risk score: a new deep learning-based signature for predicting survival in cervical cancer. Cancer Med. 2023;12(2):1051–63.PubMedCrossRef
24.
Zurück zum Zitat Ferreira M, Lovinfosse P, Hermesse J, Decuypere M, Rousseau C, Lucia F, et al. [(18)F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation. Eur J Nucl Med Mol Imaging. 2021;48(11):3432–43.PubMedPubMedCentralCrossRef Ferreira M, Lovinfosse P, Hermesse J, Decuypere M, Rousseau C, Lucia F, et al. [(18)F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation. Eur J Nucl Med Mol Imaging. 2021;48(11):3432–43.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Arezzo F, La Forgia D, Venerito V, Moschetta M, Tagliafico AS, Lombardi C, et al. A machine learning tool to predict the response to neoadjuvant chemotherapy in patients with locally advanced cervical cancer. Appl Sci. 2021;11(2):823.CrossRef Arezzo F, La Forgia D, Venerito V, Moschetta M, Tagliafico AS, Lombardi C, et al. A machine learning tool to predict the response to neoadjuvant chemotherapy in patients with locally advanced cervical cancer. Appl Sci. 2021;11(2):823.CrossRef
26.
Zurück zum Zitat Carlini G, Curti N, Strolin S, Giampieri E, Sala C, Dall’Olio D, et al. Prediction of Overall Survival in Cervical Cancer Patients Using PET/CT Radiomic Features. Appl Sci. 2022;12(12):5946.CrossRef Carlini G, Curti N, Strolin S, Giampieri E, Sala C, Dall’Olio D, et al. Prediction of Overall Survival in Cervical Cancer Patients Using PET/CT Radiomic Features. Appl Sci. 2022;12(12):5946.CrossRef
27.
Zurück zum Zitat Obrzut B, Kusy M, Semczuk A, Obrzut M, Kluska J. Prediction of 5-year overall survival in cervical cancer patients treated with radical hysterectomy using computational intelligence methods. BMC Cancer. 2017;17(1):840.PubMedPubMedCentralCrossRef Obrzut B, Kusy M, Semczuk A, Obrzut M, Kluska J. Prediction of 5-year overall survival in cervical cancer patients treated with radical hysterectomy using computational intelligence methods. BMC Cancer. 2017;17(1):840.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Matsuo K, Purushotham S, Jiang B, Mandelbaum RS, Takiuchi T, Liu Y, et al. Survival outcome prediction in cervical cancer: Cox models vs deep-learning model. Am J Obstet Gynecol. 2019;220(4):381. e1-e14.PubMedCrossRef Matsuo K, Purushotham S, Jiang B, Mandelbaum RS, Takiuchi T, Liu Y, et al. Survival outcome prediction in cervical cancer: Cox models vs deep-learning model. Am J Obstet Gynecol. 2019;220(4):381. e1-e14.PubMedCrossRef
29.
Zurück zum Zitat Han Q, Kim SI, Yoon SH, Kim TM, Kang HC, Kim HJ, et al. Impact of computed tomography-based, artificial intelligence-driven volumetric sarcopenia on survival outcomes in early cervical cancer. Front Oncol. 2021:3810. Han Q, Kim SI, Yoon SH, Kim TM, Kang HC, Kim HJ, et al. Impact of computed tomography-based, artificial intelligence-driven volumetric sarcopenia on survival outcomes in early cervical cancer. Front Oncol. 2021:3810.
30.
Zurück zum Zitat Wallbillich JJ, Tran PM, Bai S, Tran LK, Sharma AK, Ghamande SA, et al. Identification of a transcriptomic signature with excellent survival prediction for squamous cell carcinoma of the cervix. Am J Cancer Res. 2020;10(5):1534.PubMedPubMedCentral Wallbillich JJ, Tran PM, Bai S, Tran LK, Sharma AK, Ghamande SA, et al. Identification of a transcriptomic signature with excellent survival prediction for squamous cell carcinoma of the cervix. Am J Cancer Res. 2020;10(5):1534.PubMedPubMedCentral
31.
Zurück zum Zitat Lin WJ, Chen JJ. Class-imbalanced classifiers for high-dimensional data. Brief Bioinform. 2013;14(1):13–26.PubMedCrossRef Lin WJ, Chen JJ. Class-imbalanced classifiers for high-dimensional data. Brief Bioinform. 2013;14(1):13–26.PubMedCrossRef
32.
Zurück zum Zitat Li J, Zhou Z, Dong J, Fu Y, Li Y, Luan Z, et al. Predicting breast cancer 5-year survival using machine learning: A systematic review. PLoS ONE. 2021;16(4):e0250370.PubMedPubMedCentralCrossRef Li J, Zhou Z, Dong J, Fu Y, Li Y, Luan Z, et al. Predicting breast cancer 5-year survival using machine learning: A systematic review. PLoS ONE. 2021;16(4):e0250370.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Horenko I. On a scalable entropic breaching of the overfitting barrier for small data problems in machine learning. Neural Comput. 2020;32(8):1563–79.PubMedCrossRef Horenko I. On a scalable entropic breaching of the overfitting barrier for small data problems in machine learning. Neural Comput. 2020;32(8):1563–79.PubMedCrossRef
34.
Zurück zum Zitat Zhang A, Xing L, Zou J, Wu JC. Shifting machine learning for healthcare from development to deployment and from models to data. Nat Biomed Eng. 2022:1–6. Zhang A, Xing L, Zou J, Wu JC. Shifting machine learning for healthcare from development to deployment and from models to data. Nat Biomed Eng. 2022:1–6.
35.
Zurück zum Zitat Frid-Adar M, Diamant I, Klang E, Amitai M, Goldberger J, Greenspan H. GAN-based synthetic medical image augmentation for increased CNN performance in liver lesion classification. Neurocomputing. 2018;321:321–31.CrossRef Frid-Adar M, Diamant I, Klang E, Amitai M, Goldberger J, Greenspan H. GAN-based synthetic medical image augmentation for increased CNN performance in liver lesion classification. Neurocomputing. 2018;321:321–31.CrossRef
36.
Zurück zum Zitat Hajiabadi M, AlizadehSavareh B, Emami H, Bashiri A. Comparison of wavelet transformations to enhance convolutional neural network performance in brain tumor segmentation. BMC Med Inform Decis Mak. 2021;21(1):327.PubMedPubMedCentralCrossRef Hajiabadi M, AlizadehSavareh B, Emami H, Bashiri A. Comparison of wavelet transformations to enhance convolutional neural network performance in brain tumor segmentation. BMC Med Inform Decis Mak. 2021;21(1):327.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Savareh BA, Emami H, Hajiabadi M, Ghafoori M, Azimi SM. Emergence of convolutional neural network in future medicine: why and how. A review on brain tumor segmentation. Polish J Medi Phys Eng. 2018;24(1):43–53.CrossRef Savareh BA, Emami H, Hajiabadi M, Ghafoori M, Azimi SM. Emergence of convolutional neural network in future medicine: why and how. A review on brain tumor segmentation. Polish J Medi Phys Eng. 2018;24(1):43–53.CrossRef
38.
Zurück zum Zitat Ramspek CL, Jager KJ, Dekker FW, Zoccali C, van Diepen M. External validation of prognostic models: what, why, how, when and where? Clin Kidney J. 2021;14(1):49–58.PubMedCrossRef Ramspek CL, Jager KJ, Dekker FW, Zoccali C, van Diepen M. External validation of prognostic models: what, why, how, when and where? Clin Kidney J. 2021;14(1):49–58.PubMedCrossRef
39.
Zurück zum Zitat Razzaghi T, Roderick O, Safro I, Marko N. Multilevel weighted support vector machine for classification on healthcare data with missing values. PLoS One. 2016;11(5):e0155119.PubMedPubMedCentralCrossRef Razzaghi T, Roderick O, Safro I, Marko N. Multilevel weighted support vector machine for classification on healthcare data with missing values. PLoS One. 2016;11(5):e0155119.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Hoeren T. Big Data and Data Quality. In: Hoeren T, Kolany-Raiser B, editors. Big Data in Context: Legal, Social and Technological Insights. Cham: Springer International Publishing; 2018. p. 1–12.CrossRef Hoeren T. Big Data and Data Quality. In: Hoeren T, Kolany-Raiser B, editors. Big Data in Context: Legal, Social and Technological Insights. Cham: Springer International Publishing; 2018. p. 1–12.CrossRef
41.
Zurück zum Zitat Stöger K, Schneeberger D, Kieseberg P, Holzinger A. Legal aspects of data cleansing in medical AI. Comput Law Secur Rev. 2021;42:105587.CrossRef Stöger K, Schneeberger D, Kieseberg P, Holzinger A. Legal aspects of data cleansing in medical AI. Comput Law Secur Rev. 2021;42:105587.CrossRef
42.
Zurück zum Zitat Han J, Kamber M. Data mining: concepts and techniques, 2nd. University of Illinois at Urbana Champaign: Morgan Kaufmann; 2006. Han J, Kamber M. Data mining: concepts and techniques, 2nd. University of Illinois at Urbana Champaign: Morgan Kaufmann; 2006.
43.
Zurück zum Zitat Ardabili S, Mosavi A, Várkonyi-Kóczy AR, editors. Advances in Machine Learning Modeling Reviewing Hybrid and Ensemble Methods. Engineering for Sustainable Future; 2020 2020//; Cham: Springer International Publishing. Ardabili S, Mosavi A, Várkonyi-Kóczy AR, editors. Advances in Machine Learning Modeling Reviewing Hybrid and Ensemble Methods. Engineering for Sustainable Future; 2020 2020//; Cham: Springer International Publishing.
44.
Zurück zum Zitat Kazienko P, Lughofer E, Trawinski B. Editorial on the special issue “Hybrid and ensemble techniques in soft computing: recent advances and emerging trends.” Soft Comput. 2015;19(12):3353–5.CrossRef Kazienko P, Lughofer E, Trawinski B. Editorial on the special issue “Hybrid and ensemble techniques in soft computing: recent advances and emerging trends.” Soft Comput. 2015;19(12):3353–5.CrossRef
45.
Zurück zum Zitat Rajula HSR, Verlato G, Manchia M, Antonucci N, Fanos V. Comparison of conventional statistical methods with machine learning in medicine: diagnosis, drug development, and treatment. Medicina. 2020;56(9):455.PubMedPubMedCentralCrossRef Rajula HSR, Verlato G, Manchia M, Antonucci N, Fanos V. Comparison of conventional statistical methods with machine learning in medicine: diagnosis, drug development, and treatment. Medicina. 2020;56(9):455.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Vaswani A, Shazeer N, Parmar N, Uszkoreit J, Jones L, Gomez AN, et al. Attention is all you need. Adv Neural Inf Process Syst. 2017;30. Vaswani A, Shazeer N, Parmar N, Uszkoreit J, Jones L, Gomez AN, et al. Attention is all you need. Adv Neural Inf Process Syst. 2017;30.
47.
Zurück zum Zitat Vilalta R, Drissi Y. A perspective view and survey of meta-learning. Artif Intell Rev. 2002;18:77–95.CrossRef Vilalta R, Drissi Y. A perspective view and survey of meta-learning. Artif Intell Rev. 2002;18:77–95.CrossRef
48.
Zurück zum Zitat Biamonte J, Wittek P, Pancotti N, Rebentrost P, Wiebe N, Lloyd S. Quantum machine learning. Nature. 2017;549(7671):195–202.PubMedCrossRef Biamonte J, Wittek P, Pancotti N, Rebentrost P, Wiebe N, Lloyd S. Quantum machine learning. Nature. 2017;549(7671):195–202.PubMedCrossRef
49.
Zurück zum Zitat Kourou K, Exarchos KP, Papaloukas C, Sakaloglou P, Exarchos T, Fotiadis DI. Applied machine learning in cancer research: a systematic review for patient diagnosis, classification and prognosis. Comput Struct Biotechnol J. 2021;19:5546–55.PubMedPubMedCentralCrossRef Kourou K, Exarchos KP, Papaloukas C, Sakaloglou P, Exarchos T, Fotiadis DI. Applied machine learning in cancer research: a systematic review for patient diagnosis, classification and prognosis. Comput Struct Biotechnol J. 2021;19:5546–55.PubMedPubMedCentralCrossRef
Metadaten
Titel
Cervical cancer survival prediction by machine learning algorithms: a systematic review
verfasst von
Milad Rahimi
Atieh Akbari
Farkhondeh Asadi
Hassan Emami
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Cancer / Ausgabe 1/2023
Elektronische ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-10808-3

Weitere Artikel der Ausgabe 1/2023

BMC Cancer 1/2023 Zur Ausgabe

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.